Diabetes Self-Management: Nurse-Led Approach
Patients were randomized to standard care, nurse-led education intervention, or nurse-led education plus acceptance therapy.
Renal Effects: SGLT2 Inhibitors in Type 2 Diabetes
A meta-analysis compared the renal side effects of SGLT2 inhibitors in patients with type 2 diabetes.
CV Events: Safety of Insulin
A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.
Can Liraglutide Delay Diabetes Onset?
Researchers compared time to onset of diabetes in a group of patients with obesity and pre-diabetes treated with liraglutide or placebo.
Dapagliflozin: All-Cause & Cardiovascular Mortality
Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?
Combo Therapy vs Insulin: Type 2 Diabetes
The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.
Type 1 Diabetes and the Microbiome
The authors compared biopsies of the duodenal mucosa in patients with type 1 diabetes, celiac disease, and controls.
By clicking Accept, you agree to become a member of the UBM Medica Community.